Further, KD of NFIC in primary AML blasts (Supplementary Fig S4b) also significantly reduced growth ranging from 0.6-fold (sh488 vs Scr) and 0.3-fold at day 4 (Fig. 4b). This evidence concerns the gene NFIC and acute myeloid leukemia.